Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-390-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20121023.45.2-390-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spoken text |
"Madam President, the European Medicines Agency is a prime example of a successful devolved EU body which can bring tangible benefits to European citizens and consumers. Based in my own constituency of London, the EMA replaces the previous complex, bureaucratic requirements for British pharmaceutical companies to apply individually in 26 other countries in order to license their medicinal products. Instead, we have developed a one-stop shop for assessing the safety and granting product licences for innovative medicines, thus saving considerable time and money and benefiting both patients and the pharmaceutical industry, which is a major export earner for the United Kingdom.
Nevertheless the ECR, my Group, maintains serious concerns about some of the contractual arrangements and the transparency of this Agency, which of course merit further scrutiny by the Court of Auditors."@en1
|
lpv:spokenAs | |
lpv:unclassifiedMetadata | |
lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples